anti-doping category is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-05-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
Once dissolved, the material is considerably less stable than the dry solid. Aqueous solutions are usually kept cold and used within a short window, and neutral or mildly acidic buffers are preferred over strongly alkaline conditions. Freeze-thaw cycles promote aggregation and loss of material to container surfaces, so dividing a batch into single-use aliquots is standard. Adsorption to plastic and glass can lower the measured concentration, meaning solution strength may need rechecking before an experiment.
Identity and purity are established with complementary methods rather than one test. Reverse-phase high-performance liquid chromatography separates the main peak from deletion sequences and oxidized variants, and its area percentage is the usual purity figure. Mass spectrometry confirms the expected molecular mass and can flag truncations or modifications that chromatography alone might miss. Amino acid analysis and peptide mapping add sequence-level confirmation, while residual counter-ion and water content are measured separately.
A freeze-dried sample is generally the most stable form and is commonly held at minus twenty degrees Celsius or lower for long-term keeping, with brief transfers at room temperature. The solid is hygroscopic, so vials are warmed to ambient temperature before opening to prevent condensation from degrading the contents. Light exposure and repeated temperature cycling are both avoided in routine handling. Storage over a desiccant is a common laboratory practice that limits moisture uptake during repeated access.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
| Property | Value | Notes |
|---|---|---|
| Dry powder storage | -20 °C or below | Desiccated and protected from light |
| Solution storage | 2-8 °C, short term | Aliquot to avoid freeze-thaw cycling |
| Reconstitution solvent | Water or buffered saline | Near-neutral pH is generally preferred |
| Identity confirmation | Mass spectrometry | Matches expected monoisotopic mass |
| Purity assessment | Reverse-phase HPLC | Reported as main-peak area percentage |
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometers, a wavelength that captures the peptide backbone. The main peak area is reported as a percentage of total peak area, which serves as a conventional purity figure. Mass spectrometry provides an independent check on molecular mass and helps confirm the expected sequence. Additional tests may include amino acid analysis and water content determination. Results are only comparable when the same column, gradient, and detection settings are used.
Peptides are susceptible to hydrolysis, oxidation, and aggregation, and BPC-157 is no exception. The lyophilized powder form is generally more stable than a solution because residual moisture is low and molecular mobility is reduced. Once dissolved, the peptide is exposed to water, oxygen, and trace metal ions that accelerate degradation. Light exposure and repeated freeze-thaw cycles are also commonly cited as sources of loss. These general principles guide most handling recommendations found in supplier documentation.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Confirmation of identity and purity relies on standard peptide analysis techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and serves as the most common purity assay. Mass spectrometry, often coupled to that chromatography step, provides an accurate molecular mass that can be matched against the expected value. Amino acid analysis or sequencing can be added for further confirmation. Because short peptides can be produced by different synthetic routes, laboratories usually report both a chromatographic purity percentage and a mass confirmation rather than a single figure.
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
Dry powder is generally stored at low temperature, with minus twenty degrees Celsius or colder advised for extended retention. Reconstituted solutions are less stable than the solid form and are normally kept cold and shielded from repeated freeze-thaw cycles. Light exposure is avoided because some peptides degrade under ultraviolet radiation. The exact rate of degradation depends on concentration, pH, and the presence of salts, so a single shelf life does not apply to every preparation. Reported stability figures should be read as indicative of typical handling rather than as universal constants.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
==== Below 1% ==== There are few studies of the health effects of long-term continuous CO2 exposure on humans and animals at levels below 1%. Occupational CO2 exposure limits have been set in the United States at 0.5% (5000 ppm) for an eight-hour period. At this CO2 concentration, International Space Station crew experienced headaches, lethargy, mental slowness, emotional irritation, and sleep disruption. Studies in animals at 0.5% CO2 have demonstrated kidney calcification and bone loss after eight weeks of exposure. A study of humans exposed in 2.5 hour sessions demonstrated significant negative effects on cognitive abilities at concentrations as low as 0.1% (1000 ppm) CO2 likely due to CO2 induced increases in cerebral blood flow. Another study observed a decline in basic activity level and information usage at 1000 ppm, when compared to 500 ppm. However a review of the literature found that a reliable subset of studies on the phenomenon of carbon dioxide induced cognitive impairment to only show a small effect on high-level decision making (for concentrations below 5000 ppm). Most of the studies were confounded by inadequate study designs, environmental comfort, uncertainties in exposure doses and differing cognitive assessments used. Similarly a study on the effects of the concentration of CO2 in motorcycle helmets has been criticized for having dubious methodology in not noting the self-reports of motorcycle riders and taking measurements using mannequins.
==== Tandem Mobi ==== The Tandem Mobi system is an automated insulin delivery AID system developed by Tandem Diabetes Care. It is powered by Control‑IQ+ technology (commercially launched in March 2025) which utilizes continuous glucose monitoring CGM sensor data to predict glucose levels 30 minutes in advance and adjust insulin delivery accordingly. The system can automatically deliver correction boluses, a feature referred to as AutoBolus, to help reduce the risk of hyperglycemia. Tandem Mobi is the only AID system that allows full control through a compatible mobile application, including on iPhone devices.
==== Filopodia ==== Filopodia are thin extensions of the plasma membrane that contain parallel bundles of actin filaments, in contrast to the branched actin structures of lamellipodia. They serve an exploratory role, being used by cells to probe their environment. While the presence of filopodia is linked to enhanced cell migration, they are not directly involved in cell body displacement.
== Role in obesity == AgRP induces obesity by chronic antagonism of the MC4-R. Overexpression of AgRP in transgenic mice (or intracerebroventricular injection) causes hyperphagia and obesity, whilst AgRP plasma levels have been found to be elevated in obese human males. Understanding the role AgRP plays in weight gain may assist in developing pharmaceutical models for treating obesity. AgRP mRNA levels have been found to be down regulated following an acute stressful event. Studies suggest that systems involved in the regulation of stress response and of energy balance are highly integrated. Loss or gain of AgRP function may result in inadequate adaptive behavioural responses to environmental events, such as stress, and have potential to contribute to the development of eating disorders. It has been shown that polymorphisms in the AgRP gene have been linked with anorexia nervosa as well as obesity. Some studies suggest that inadequate signalling of AgRP during stress may result in binge eating. Starvation-induced hypothalamic autophagy generates free fatty acids, which in turn regulate neuronal AgRP levels.
in excess of 3 metres (9.8 feet) have been collected on several occasions, representing probable ages in excess of 400 years (Fisher, 1995). Vestimentiferan tube worm spawning is not seasonal, and recruitment is episodic. Tubeworms are either male or female. One recent discovery indicates that the spawning of female Lamellibrachia appears to have produced a unique association with the large bivalve Acesta bullisi, which lives permanently attached to the anterior tube opening of the tubeworm, and feeds on the periodic egg release (Järnegren et al., 2005). This close association between the bivalves and tubeworms was discovered in 1984 (Boland, 1986) but not fully explained. Virtually all mature Acesta individuals are found on female rather than male tubeworms. This evidence and other experiments by Järnegren et al. (2005) seem to have solved this mystery. Growth rates for methanotrophic mussels at cold seep sites have been reported (Fisher, 1995). General growth rates were found to be relatively high. Adult mussel growth rates were similar to mussels from a littoral environment at similar temperatures. Fisher also found that juvenile mussels at hydrocarbon seeps initially grow rapidly, but the growth rate drops markedly in adults; they grow to reproductive size very quickly. Both individuals and communities appear to be very long-lived. These methane-dependent mussels have strict chemical requirements that tie them to areas of the most active seepage in the Gulf of Mexico.
Sources: en.wikipedia.org
== Adaptations == In 2000, Yahoo! reported that MGM and actor/director Tom Hanks were in discussions regarding adapting both 2061: Odyssey Three and 3001: The Final Odyssey into movies, with Hanks reportedly to play Frank Poole in the 3001 film. An update in 2001 stated that there was no further development on the project. On 3 November 2014, it was reported that the US TV channel Syfy had ordered a miniseries adaptation of 3001: The Final Odyssey into production, planned for broadcast in 2015. The miniseries would be executive-produced by Ridley Scott, David W. Zucker and Stuart Beattie; the latter would also be the primary script-writer. The estates of both Clarke and 2001: A Space Odyssey director Stanley Kubrick were reported as having "offered their full support", but the extent of their involvement was not known at the time. In February 2016, within Syfy's press release for its television pilot Prototype, other series including the Final Odyssey series were mentioned as being in development. However, to date, no further progress has been made. The plot of Futurama has similarities, with the character of Fry being frozen for 1000 years (albeit in 1999) and waking in the year 3000.
=== EC 2.6.1: Transaminases === EC 2.6.1.1: aspartate transaminase EC 2.6.1.2: alanine transaminase EC 2.6.1.3: cysteine transaminase EC 2.6.1.4: glycine transaminase EC 2.6.1.5: tyrosine transaminase EC 2.6.1.6: leucine transaminase EC 2.6.1.7: kynurenine—oxoglutarate transaminase EC 2.6.1.8: deleted EC 2.6.1.9: histidinol-phosphate transaminase EC 2.6.1.10: deleted, included with EC 2.6.1.21, D-amino-acid transaminase EC 2.6.1.11: acetylornithine transaminase EC 2.6.1.12: alanine—oxo-acid transaminase EC 2.6.1.13: ornithine aminotransferase EC 2.6.1.14: asparagine—oxo-acid transaminase EC 2.6.1.15: glutamine—pyruvate transaminase EC 2.6.1.16: glutamine—fructose-6-phosphate transaminase (isomerizing) EC 2.6.1.17: succinyldiaminopimelate transaminase EC 2.6.1.18: β-alanine—pyruvate transaminase EC 2.6.1.19: 4-aminobutyrate transaminase EC 2.6.1.20: deleted EC 2.6.1.21: D-amino-acid transaminase EC 2.6.1.22: (S)-3-amino-2-methylpropionate transaminase EC 2.6.1.23: 4-hydroxyglutamate transaminase EC 2.6.1.24: diiodotyrosine transaminase EC 2.6.1.25: deleted, Now included with EC 2.6.1.24 diiodotyrosine transaminase EC 2.6.1.26: thyroid-hormone transaminase EC 2.6.1.27: tryptophan transaminase EC 2.6.1.28: tryptophan—phenylpyruvate transaminase EC 2.6.1.29: diamine transaminase EC 2.6.1.30: pyridoxamine—pyruvate transaminase EC 2.6.1.31: pyridoxamine—oxaloacetate transaminase EC 2.6.1.32: valine—3-methyl-2-oxovalerate transaminase EC 2.6.1.33: dTDP-4-amino-4,6-dideoxy-D-glucose transaminase EC 2.6.1.34: UDP-N-acetylbacillosamine transaminase EC 2.6.1.35: glycine—oxaloacetate transaminase EC 2.6.1.36: L-lysine 6-transaminase EC 2.6.1.37: (2-aminoethyl)phosphonate—pyruvate transaminase EC 2.6.1.38: histidine transaminase EC 2.6.1.39: 2-aminoadipate transaminase EC 2.6.1.40: (R)-3-amino-2-methylpropionate—pyruvate transaminase EC 2.6.1.41: D-methionine—pyruvate transaminase EC 2.6.1.42: branched-chain-amino-acid transaminase EC 2.6.1.43: aminolevulinate transaminase EC 2.6.1.44: alanine—glyoxylate transaminase EC 2.6.1.45: serine—glyoxylate transaminase EC 2.6.1.46: diaminobutyrate—pyruvate transaminase EC 2.6.1.47: alanine—oxomalonate transaminase EC 2.6.1.48: 5-aminovalerate transaminase EC 2.6.1.49: dihydroxyphenylalanine transaminase EC 2.6.1.50: glutamine—scyllo-inositol transaminase EC 2.6.1.51: serine—pyruvate transaminase EC 2.6.1.52: phosphoserine transaminase EC 2.6.1.53: Now EC 1.4.1.13, glutamate synthase (NADPH) EC 2.6.1.54: pyridoxamine-phosphate transaminase EC 2.6.1.55: taurine—2-oxoglutarate transaminase EC 2.6.1.56: 1D-1-guanidino-3-amino-1,3-dideoxy-scyllo-inositol transaminase EC 2.6.1.57: aromatic-amino-acid transaminase EC 2.6.1.58: phenylalanine(histidine) transaminase EC 2.6.1.59: dTDP-4-amino-4,6-dideoxygalactose transaminase EC 2.6.1.60: aromatic-amino-acid—glyoxylate transaminase EC 2.6.1.61: identical to EC 2.6.1.40, (R)-3-amino-2-methylpropionate—pyruvate transaminase EC 2.6.1.62: adenosylmethionine—8-amino-7-oxononanoate transaminase EC 2.6.1.63: kynurenine—glyoxylate transaminase EC 2.6.1.64: glutamine—phenylpyruvate transaminase EC 2.6.1.65: N6-acetyl-β-lysine transaminase EC 2.6.1.66: valine—pyruvate transaminase EC 2.6.1.67: 2-aminohexanoate transaminase EC 2.6.1.68: Now classified as EC 2.6.1.13, ornithine aminotransferase and EC 2.6.1.36, L-lysine 6-transaminase EC 2.6.1.69: identical to EC 2.6.1.11, ((acetylornithine transaminase))|identical to EC 2.6.1.11, acetylornithine transaminase EC 2.6.1.70: aspartate—phenylpyruvate transaminase EC 2.6.1.71: lysine—pyruvate 6-transaminase EC 2.6.1.72: D-4-hydroxyphenylglycine transaminase EC 2.6.1.73: methionine—glyoxylate transaminase EC 2.6.1.74: cephalosporin-C transaminase EC 2.6.1.75: cysteine-conjugate transaminase EC 2.6.1.76: diaminobutyrate—2-oxoglutarate transaminase EC 2.6.1.77: taurine—pyruvate aminotransferase EC 2.6.1.78: aspartate—prephenate aminotransferase EC 2.6.1.79: glutamate—prephenate aminotransferase EC 2.6.1.80: nicotianamine aminotransferase EC 2.6.1.81: succinylornithine transaminase EC 2.6.1.82: putrescine aminotransferase EC 2.6.1.83: LL-diaminopimelate aminotransferase EC 2.6.1.84: arginine—pyruvate transaminase EC 2.6.1.85: aminodeoxychorismate synthase EC 2.6.1.86: 2-amino-4-deoxychorismate synthase EC 2.6.1.87: UDP-4-amino-4-deoxy-L-arabinose aminotransferase EC 2.6.1.88: methionine transaminase EC 2.6.1.89: dTDP-3-amino-3,6-dideoxy-α-D-glucopyranose transaminase EC 2.6.1.90: dTDP-3-amino-3,6-dideoxy-α-D-galactopyranose transaminase EC 2.6.1.91: Identical to EC 2.6.1.34, UDP-N-acetylbacillosamine transaminase EC 2.6.1.92: UDP-4-amino-4,6-dideoxy-N-acetyl-β-L-altrosamine transaminase EC 2.6.1.93: neamine transaminase EC 2.6.1.94: 2′-deamino-2′-hydroxyneamine transaminase EC 2.6.1.95: neomycin C transaminase EC 2.6.1.96: 4-aminobutyrate—pyruvate transaminase EC 2.6.1.97: archaeosine synthase EC 2.6.1.98: UDP-2-acetamido-2-deoxy-ribo-hexuluronate aminotransferase EC 2.6.1.99: L-tryptophan—pyruvate aminotransferase EC 2.6.1.100: L-glutamine:2-deoxy-scyllo-inosose aminotransferase EC 2.6.1.101: L-glutamine:3-amino-2,3-dideoxy-scyllo-inosose aminotransferase EC 2.6.1.102: GDP-perosamine synthase EC 2.6.1.103: (S)-3,5-dihydroxyphenylglycine transaminase EC 2.6.1.104: 3-dehydro-glucose-6-phosphate—glutamate transaminase EC 2.6.1.105: lysine—8-amino-7-oxononanoate transaminase EC 2.6.1.106: dTDP-3-amino-3,4,6-trideoxy-α-D-glucose transaminase EC 2.6.1.107: β-methylphenylalanine transaminase EC 2.6.1.108: (5-formylfuran-3-yl)methyl phosphate transaminase EC 2.6.1.109: 8-amino-3,8-dideoxy-α-D-manno-octulosonate transaminase EC 2.6.1.110: dTDP-4-dehydro-2,3,6-trideoxy-D-glucose 4-aminotransferase EC 2.6.1.111: 3-aminobutanoyl-CoA transaminase EC 2.6.1.112: (S)-ureidoglycine—glyoxylate transaminase EC 2.6.1.113: putrescine—pyruvate transaminase EC 2.6.1.114: 8-demethyl-8-aminoriboflavin-5′-phosphate synthase EC 2.6.1.115: 5-hydroxydodecatetraenal 1-aminotransferase EC 2.6.1.116: 6-aminohexanoate aminotransferase EC 2.6.1.117: L-glutamine—4-(methylsulfanyl)-2-oxobutanoate aminotransferase EC 2.6.1.118: [amino-group carrier protein]-γ-(L-lysyl)-L-glutamate aminotransferase EC 2.6.1.119: vanillin aminotransferase
== Resonance assignment == In order to analyze the nuclear magnetic resonance data, it is important to get a resonance assignment for the protein, that is to find out which chemical shift corresponds to which atom. This is typically achieved by sequential walking using information derived from several different types of NMR experiment. The exact procedure depends on whether the protein is isotopically labelled or not, since a lot of the assignment experiments depend on carbon-13 and nitrogen-15.
Susan M Gaines is an American writer. She is the author of the novels Accidentals (2020) and Carbon Dreams (2001), and co-author with Geoffrey Eglinton and Jurgen Rullkötter of the science book Echoes of Life: What Fossil Molecules Reveal about Earth History (2009). Her short stories have been nominated twice for the Pushcart Prize. She is a former fellow of the Hanse Institute for Advanced Study in Germany. In 2018, she was awarded a Suffrage Science Award for women in science and science writers who have inspired others.
==== Member of the Order of the British Empire (MBE) ==== Military Commander Steven Andrews, Royal Navy, D257452S. Lieutenant Commander Ross Donald Balfour, Royal Navy, C040712E. Warrant Officer 1 James Adrian Cuthbert, Royal Marines, P047210N. Warrant Officer 1 Engineering Technician (Communication and Information Systems) Steven Gilbertson, Royal Navy, D242982T. Commander Martin John Howard, Royal Navy, C041681L. Lieutenant Commander Alexander Rowan Marsh, Royal Navy, 30033538. Commander Paul O'Dooley, Royal Naval Reserve, C900344D. Chief Petty Officer Engineering Technician (Marine Engineering) Michael John Stephens, Royal Navy, D258366B. Leading Seaman (Diver) Rory Edward Cartwright-Taylor, Royal Navy, 30050838. Lieutenant Sam David Thompson, Royal Navy, 30023663. Commander Roger Simon Wyness, Royal Navy, C037182G. Major John Edward BAILEFF, Royal Regiment of Artillery, 30121479. Major Allan Paul Beard, Intelligence Corps, 25132230. Sergeant Daniel Adam Powderham-Bissell, Intelligence Corps, 25179642. Lieutenant Colonel John George Bradbury, Corps of Royal Electrical and Mechanical Engineers, Army Reserve, 552247. Major (now Acting Lieutenant Colonel) Keith Michael Timothy Brooks, , Royal Regiment of Artillery, Army Reserve, 511819. Captain Barry Lee Byron, , General Service Corps, Army Reserve, 24751476. Captain Giles Alexander Leighton Clarke, The Royal Logistic Corps, 30082571. Major Lisa Jane Clarke, Adjutant General's Corps (Staff and Personnel Support Branch), W0815832. Major James Philip Dott, The Parachute Regiment, 30011021.
Sources: en.wikipedia.org
Zircon contains high amount of uranium for machine recognition, commonly 100–1000 ppm. Zircon has a low amount of lead during crystallization, in parts per trillion. Thus, lead found in zircon can be assumed as daughter nuclei from parent uranium. Zircon crystals grow between 600 and 1100 °C, while lead is retained within the crystal structure below 800 °C (see Closure temperature). So once zircon has cooled below 800 °C it retains all the lead from the radioactive decay. Therefore, U-Pb age can be treated as the age of crystallization, if the mineral/sample itself has not undergone high temperature metamorphism after formation. Zircon commonly crystallizes in felsic igneous rocks, with greater than 60% silica (SiO2) content. These rocks are generally less dense and more buoyant. They sit high in the Earth's (continental crust), and have good preservation potential. Zircon is physically and chemically resistant, so it is more likely to be preserved in the sedimentary cycle. Zircon contains other elements which gives supplementary information, such as hafnium (Hf), uranium/thorium (U/Th) ratio.
A pariah field, cast out by the scientific establishment. Between cold fusion and respectable science there is virtually no communication at all. Cold fusion papers are almost never published in refereed scientific journals, with the result that those works don't receive the normal critical scrutiny that science requires. On the other hand, because the Cold-Fusioners see themselves as a community under siege, there is little internal criticism. Experiments and theories tend to be accepted at face value, for fear of providing even more fuel for external critics, if anyone outside the group was bothering to listen. In these circumstances, crackpots flourish, making matters worse for those who believe that there is serious science going on here.
==== Earlier German rations ==== In the field, the Wehrmacht were provided rations from field kitchens based on the garrison ration. However additional classes of ration were available. The march ration was a cold food ration issued for not more than three or four consecutive days to units in transit either on carrier or by foot. It consisted of approximately 700 grams of bread, 200 grams of cold meat or cheese, 60 grams of bread spreads, 9 grams of coffee (or 4 grams of tea), 10 grams of sugar, and six cigarettes. The ration had a total weight of about 980 grams. An iron ration consisted of 250 grams of biscuits, 200 grams of cold meat, 150 of preserved vegetables, 25 of coffee, and 25 of salt. The total weight of the iron ration was 650 grams without packing and 825 grams with packing. An iron half-ration was composed of 250 grams of biscuits and 200 grams of preserved meat; thus its total weight was 450 grams without packing and 535 grams with packing.
However, when P is on the circumcircle the sum of the distances from P to the nearest two vertices exactly equals the distance to the farthest vertex. A triangle is equilateral if and only if, for every point P in the plane, with distances PD, PE, and PF to the triangle's sides and distances PA, PB, and PC to its vertices,
These findings are based on decades of data, and control for cohort groups; the data avoids the risk that the drops in happiness during midlife are due to populations' unique midlife experiences, like a war. The studies have also controlled for income, job status and parenting (as opposed to childlessness) to try to isolate the effects of age. Researchers found support for the notion of age changes inside the individual that affect happiness. This could be for any number of reasons. Psychological factors could include greater awareness of one's self and preferences; an ability to control desires and have more realistic expectations – unrealistic expectations tend to foster unhappiness; moving closer to death may motivate people to pursue personal goals; improved social skills, like forgiveness, may take years to develop – the practice of forgiveness seems linked to higher levels of happiness; or happier people may live longer and are slightly overrepresented in the elderly population. Age-related chemical changes might also play a role. Other studies have found older individuals reported more health problems, but fewer problems overall. Young adults reported more anger, anxiety, depression, financial problems, troubled relationships and career stress. Researchers also suggest depression in the elderly is often due largely to passivity and inaction – they recommend people continue to undertake activities that bring happiness, even in old age.
Sources: en.wikipedia.org
Low temperature slows the chemical reactions, such as oxidation and hydrolysis, that break down a peptide chain. Water and oxygen are the main drivers of degradation, so a cold and dry environment extends usable life. Actual shelf life depends on the batch, the salt form, and the container.
It normally reports the share of the chromatographic signal that belongs to the main peak, not a measure of activity. A high figure means few related substances were detected under the stated method and wavelength. Different laboratories and methods can return different values for the same material.
Retention time alone is weak evidence, because unrelated peptides can elute at similar positions. Amino acid analysis or peptide mapping gives stronger sequence information when a mass spectrometer is unavailable. Most laboratories still treat mass confirmation as the standard step for verifying the correct compound.
It is a synthetic peptide. Its design was inspired by a fragment of a protein found in human gastric juice, but the fifteen-amino-acid molecule itself is made in a laboratory and is not a normal component of food or of human tissue in appreciable amounts.